The results demonstrated that the PI3K/Akt and HIF-1α signaling pathways were among the top three pathways exhibiting the most significant changes, further emphasizing their importance in sorafenib resistance in HCC. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.